Dopaminergic agents (anti-parkinson drug)

Key figures
Data
Graphics
Comments

PRESCRIBERS
Main prescribers: General practitioners	60.72%
INSURED CONSUMERS
% of insured consumers	0.68%
Median age	75 years
Max/min ratio of the median age (by district)	1.10
Percentage of women	55.34%
Ratio Preferential scheme/General scheme	1.50
Coefficient of variation (2022)	15.13
Max/min ratio of % of insured consumers (by district)	1.60
CONSUMPTION
Annual consumption (DDD)	18,670,473
Consumption of DDD (per 100,000 insured persons)	162,226.39
% DDD issued outside the insurance (approximate)	2.70%
Average annual consumption per insured consumer (DDD)	237.23
% of insured consumers with > 3 times the average consumption	8,85%
Coefficient of variation 2013-2015	17.27
Coefficient of variation 2020-2022	17.36
Trend 2013-2022	0.25%
Trend 2013-2019	0.87%
Trend 2019-2022	-0.99%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance	21,336,025€
Average annual expenditure per insured person	1.85 €
Average patient share per insured consumer	17.23%
Max/min ratio of expenditure per insured person (by disctrict)	1.85
% “Low-cost” medication	90.17%
Trend 2013-2022	-3.92%
Trend 2019-2022	-2.38%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

+ - ATC codes selected for analysis Click to collapse

CODES (ATC-5)	LABELS
N04BA	DOPA AND DOPA DERIVATIVES
N04BB	ADAMANTANE DERIVATIVES
N04BC	DOPAMINE AGONISTS
N04BD	MONOAMINE OXIDASE B INHIBITORS
N04BX	OTHER DOPAMINERGIC AGENTS